Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15

CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece

Total article views   HTML views PDF downloads Totals
3,366 Dovepress* 3,211+ 143 3,354
PubMed Central* 155 69 224
Totals 3,366 212 3,578
*Since 17 February 2023

View citations on PubMed Central and Google Scholar